medical cannabis investing

Strainprint™ Closes USD $3 Million (Cdn.$3.8M) Series A Funding

TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]

Strainprint Featured in Direct Cannabis Network: Strainprint ™ App,Tracking Your Cannabis Intake

  Whether you are a medical cannabis patient or a recreational user, tracking your cannabis consumption habits are not only essential but also largely beneficial. Some people find it helpful to chronical their treatment journey in a paper-based journal but often find it inconvenient to capture each interaction and thus have an inaccurate record of […]

Strainprint Technologies Ltd. Featured On Blyss Cloud: WHY WE LOVE THE WELLNESS APP STRAINPRINT

Recently, the Strainprint App was featured on Blyss Cloud. Read all about why they love the Strainprint App!

Strainprint™ Technologies Ltd. Launches Custom-Branded OEM Version of Industry-Leading Mobile Cannabis Journaling App for Canna Farms

Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.

Strainprint Weedbox Feature: Wanna Smoke More of the Right Weed? There's An App for That!

Recently, Strainprint was featured on Weedbox. Stephanie Karasick, Founder of Strainprint was interviewed about the app. Read her full interview and learn all about Strainprint below!   View Article  

Strainprint Featured on the Investing News Network: Software Company Strainprint Wants to Change the Limitations of Medical Cannabis Research

On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.